SCHEMBL27777545

SCHEMBL27777545

CC1=C(C(N)=O)SC(n2cnn(CC3CC3)c2=O)N1Cc1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 3/20 0.47
▸ HTT P42858 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36
▸ PKM P14618 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ POLB P06746 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27837979 0.91 SCD (0.39) SCDHTTCYP3A4CYP2C9CYP2C19
SCHEMBL27855654 0.89 SCD (0.37) SCDKDM4EPOLBKMT2APARP1
SCHEMBL27777551 0.88 ALDH1A1 (0.37) SCDHTTALDH1A1MAPTKDM4E
SCHEMBL27777529 0.85 SCD (0.47) SCDCYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL27957016 0.84 SCD (0.48) SCDALDH1A1KDM4EPKMSMN1; SMN2
SCHEMBL27855734 0.83 SIRT1 (0.36) SCDALDH1A1KDM4ETSHRMAPK1
SCHEMBL27777547 0.83 SCD (0.48) SCDALDH1A1MAPTKDM4ETSHR
SCHEMBL27777549 0.83 SCD (0.34) SCDALDH1A1MAPTKDM4ETSHR
SCHEMBL27756654 0.83 SCD (0.49) SCD
SCHEMBL27777542 0.82 ALDH1A1 (0.39) HTTCYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101535303-A Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level NOVARTIS AG (CH) 2009-09-16 — — CN claimed
CN-101535303-B Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level NOVARTIS AG 2012-07-18 — — CN disclosed
CN-101535303-A Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level NOVARTIS AG (CH) 2009-09-16 — — CN disclosed
Send feedback